Request for Covid-19 Impact Assessment of this Report
The United States Tolbutamide (CAS 64-77-7) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tolbutamide (CAS 64-77-7) market, reaching US$ million by the year 2028. As for the Europe Tolbutamide (CAS 64-77-7) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Tolbutamide (CAS 64-77-7) players cover Pengyao Pharma, SINE, Changzhou Pharma, and Changjiang Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Tolbutamide (CAS 64-77-7) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral
Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pengyao Pharma
SINE
Changzhou Pharma
Changjiang Pharma
EASHU Pharma
Mylan
Sovereign
Vexxa LifeScience
Genesis Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tolbutamide (CAS 64-77-7) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Tolbutamide (CAS 64-77-7) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Tolbutamide (CAS 64-77-7) by Country/Region, 2017, 2022 & 2028
2.2 Tolbutamide (CAS 64-77-7) Segment by Type
2.2.1 Oral
2.2.2 Injection
2.3 Tolbutamide (CAS 64-77-7) Sales by Type
2.3.1 Global Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2017-2022)
2.3.2 Global Tolbutamide (CAS 64-77-7) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Tolbutamide (CAS 64-77-7) Sale Price by Type (2017-2022)
2.4 Tolbutamide (CAS 64-77-7) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Tolbutamide (CAS 64-77-7) Sales by Application
2.5.1 Global Tolbutamide (CAS 64-77-7) Sale Market Share by Application (2017-2022)
2.5.2 Global Tolbutamide (CAS 64-77-7) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Tolbutamide (CAS 64-77-7) Sale Price by Application (2017-2022)
3 Global Tolbutamide (CAS 64-77-7) by Company
3.1 Global Tolbutamide (CAS 64-77-7) Breakdown Data by Company
3.1.1 Global Tolbutamide (CAS 64-77-7) Annual Sales by Company (2020-2022)
3.1.2 Global Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2020-2022)
3.2 Global Tolbutamide (CAS 64-77-7) Annual Revenue by Company (2020-2022)
3.2.1 Global Tolbutamide (CAS 64-77-7) Revenue by Company (2020-2022)
3.2.2 Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Company (2020-2022)
3.3 Global Tolbutamide (CAS 64-77-7) Sale Price by Company
3.4 Key Manufacturers Tolbutamide (CAS 64-77-7) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tolbutamide (CAS 64-77-7) Product Location Distribution
3.4.2 Players Tolbutamide (CAS 64-77-7) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tolbutamide (CAS 64-77-7) by Geographic Region
4.1 World Historic Tolbutamide (CAS 64-77-7) Market Size by Geographic Region (2017-2022)
4.1.1 Global Tolbutamide (CAS 64-77-7) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Tolbutamide (CAS 64-77-7) Annual Revenue by Geographic Region
4.2 World Historic Tolbutamide (CAS 64-77-7) Market Size by Country/Region (2017-2022)
4.2.1 Global Tolbutamide (CAS 64-77-7) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Tolbutamide (CAS 64-77-7) Annual Revenue by Country/Region
4.3 Americas Tolbutamide (CAS 64-77-7) Sales Growth
4.4 APAC Tolbutamide (CAS 64-77-7) Sales Growth
4.5 Europe Tolbutamide (CAS 64-77-7) Sales Growth
4.6 Middle East & Africa Tolbutamide (CAS 64-77-7) Sales Growth
5 Americas
5.1 Americas Tolbutamide (CAS 64-77-7) Sales by Country
5.1.1 Americas Tolbutamide (CAS 64-77-7) Sales by Country (2017-2022)
5.1.2 Americas Tolbutamide (CAS 64-77-7) Revenue by Country (2017-2022)
5.2 Americas Tolbutamide (CAS 64-77-7) Sales by Type
5.3 Americas Tolbutamide (CAS 64-77-7) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tolbutamide (CAS 64-77-7) Sales by Region
6.1.1 APAC Tolbutamide (CAS 64-77-7) Sales by Region (2017-2022)
6.1.2 APAC Tolbutamide (CAS 64-77-7) Revenue by Region (2017-2022)
6.2 APAC Tolbutamide (CAS 64-77-7) Sales by Type
6.3 APAC Tolbutamide (CAS 64-77-7) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tolbutamide (CAS 64-77-7) by Country
7.1.1 Europe Tolbutamide (CAS 64-77-7) Sales by Country (2017-2022)
7.1.2 Europe Tolbutamide (CAS 64-77-7) Revenue by Country (2017-2022)
7.2 Europe Tolbutamide (CAS 64-77-7) Sales by Type
7.3 Europe Tolbutamide (CAS 64-77-7) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tolbutamide (CAS 64-77-7) by Country
8.1.1 Middle East & Africa Tolbutamide (CAS 64-77-7) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Tolbutamide (CAS 64-77-7) Revenue by Country (2017-2022)
8.2 Middle East & Africa Tolbutamide (CAS 64-77-7) Sales by Type
8.3 Middle East & Africa Tolbutamide (CAS 64-77-7) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tolbutamide (CAS 64-77-7)
10.3 Manufacturing Process Analysis of Tolbutamide (CAS 64-77-7)
10.4 Industry Chain Structure of Tolbutamide (CAS 64-77-7)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tolbutamide (CAS 64-77-7) Distributors
11.3 Tolbutamide (CAS 64-77-7) Customer
12 World Forecast Review for Tolbutamide (CAS 64-77-7) by Geographic Region
12.1 Global Tolbutamide (CAS 64-77-7) Market Size Forecast by Region
12.1.1 Global Tolbutamide (CAS 64-77-7) Forecast by Region (2023-2028)
12.1.2 Global Tolbutamide (CAS 64-77-7) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tolbutamide (CAS 64-77-7) Forecast by Type
12.7 Global Tolbutamide (CAS 64-77-7) Forecast by Application
13 Key Players Analysis
13.1 Pengyao Pharma
13.1.1 Pengyao Pharma Company Information
13.1.2 Pengyao Pharma Tolbutamide (CAS 64-77-7) Product Offered
13.1.3 Pengyao Pharma Tolbutamide (CAS 64-77-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pengyao Pharma Main Business Overview
13.1.5 Pengyao Pharma Latest Developments
13.2 SINE
13.2.1 SINE Company Information
13.2.2 SINE Tolbutamide (CAS 64-77-7) Product Offered
13.2.3 SINE Tolbutamide (CAS 64-77-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 SINE Main Business Overview
13.2.5 SINE Latest Developments
13.3 Changzhou Pharma
13.3.1 Changzhou Pharma Company Information
13.3.2 Changzhou Pharma Tolbutamide (CAS 64-77-7) Product Offered
13.3.3 Changzhou Pharma Tolbutamide (CAS 64-77-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Changzhou Pharma Main Business Overview
13.3.5 Changzhou Pharma Latest Developments
13.4 Changjiang Pharma
13.4.1 Changjiang Pharma Company Information
13.4.2 Changjiang Pharma Tolbutamide (CAS 64-77-7) Product Offered
13.4.3 Changjiang Pharma Tolbutamide (CAS 64-77-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Changjiang Pharma Main Business Overview
13.4.5 Changjiang Pharma Latest Developments
13.5 EASHU Pharma
13.5.1 EASHU Pharma Company Information
13.5.2 EASHU Pharma Tolbutamide (CAS 64-77-7) Product Offered
13.5.3 EASHU Pharma Tolbutamide (CAS 64-77-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 EASHU Pharma Main Business Overview
13.5.5 EASHU Pharma Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Tolbutamide (CAS 64-77-7) Product Offered
13.6.3 Mylan Tolbutamide (CAS 64-77-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Sovereign
13.7.1 Sovereign Company Information
13.7.2 Sovereign Tolbutamide (CAS 64-77-7) Product Offered
13.7.3 Sovereign Tolbutamide (CAS 64-77-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sovereign Main Business Overview
13.7.5 Sovereign Latest Developments
13.8 Vexxa LifeScience
13.8.1 Vexxa LifeScience Company Information
13.8.2 Vexxa LifeScience Tolbutamide (CAS 64-77-7) Product Offered
13.8.3 Vexxa LifeScience Tolbutamide (CAS 64-77-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Vexxa LifeScience Main Business Overview
13.8.5 Vexxa LifeScience Latest Developments
13.9 Genesis Pharma
13.9.1 Genesis Pharma Company Information
13.9.2 Genesis Pharma Tolbutamide (CAS 64-77-7) Product Offered
13.9.3 Genesis Pharma Tolbutamide (CAS 64-77-7) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Genesis Pharma Main Business Overview
13.9.5 Genesis Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Tolbutamide (CAS 64-77-7) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Tolbutamide (CAS 64-77-7) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Global Tolbutamide (CAS 64-77-7) Sales by Type (2017-2022) & (Kg)
Table 6. Global Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2017-2022)
Table 7. Global Tolbutamide (CAS 64-77-7) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Type (2017-2022)
Table 9. Global Tolbutamide (CAS 64-77-7) Sale Price by Type (2017-2022) & (USD/Kg)
Table 10. Global Tolbutamide (CAS 64-77-7) Sales by Application (2017-2022) & (Kg)
Table 11. Global Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2017-2022)
Table 12. Global Tolbutamide (CAS 64-77-7) Revenue by Application (2017-2022)
Table 13. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Application (2017-2022)
Table 14. Global Tolbutamide (CAS 64-77-7) Sale Price by Application (2017-2022) & (USD/Kg)
Table 15. Global Tolbutamide (CAS 64-77-7) Sales by Company (2020-2022) & (Kg)
Table 16. Global Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2020-2022)
Table 17. Global Tolbutamide (CAS 64-77-7) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Company (2020-2022)
Table 19. Global Tolbutamide (CAS 64-77-7) Sale Price by Company (2020-2022) & (USD/Kg)
Table 20. Key Manufacturers Tolbutamide (CAS 64-77-7) Producing Area Distribution and Sales Area
Table 21. Players Tolbutamide (CAS 64-77-7) Products Offered
Table 22. Tolbutamide (CAS 64-77-7) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tolbutamide (CAS 64-77-7) Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Tolbutamide (CAS 64-77-7) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Tolbutamide (CAS 64-77-7) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Tolbutamide (CAS 64-77-7) Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Tolbutamide (CAS 64-77-7) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Tolbutamide (CAS 64-77-7) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Tolbutamide (CAS 64-77-7) Sales by Country (2017-2022) & (Kg)
Table 34. Americas Tolbutamide (CAS 64-77-7) Sales Market Share by Country (2017-2022)
Table 35. Americas Tolbutamide (CAS 64-77-7) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Tolbutamide (CAS 64-77-7) Revenue Market Share by Country (2017-2022)
Table 37. Americas Tolbutamide (CAS 64-77-7) Sales by Type (2017-2022) & (Kg)
Table 38. Americas Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2017-2022)
Table 39. Americas Tolbutamide (CAS 64-77-7) Sales by Application (2017-2022) & (Kg)
Table 40. Americas Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2017-2022)
Table 41. APAC Tolbutamide (CAS 64-77-7) Sales by Region (2017-2022) & (Kg)
Table 42. APAC Tolbutamide (CAS 64-77-7) Sales Market Share by Region (2017-2022)
Table 43. APAC Tolbutamide (CAS 64-77-7) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Tolbutamide (CAS 64-77-7) Revenue Market Share by Region (2017-2022)
Table 45. APAC Tolbutamide (CAS 64-77-7) Sales by Type (2017-2022) & (Kg)
Table 46. APAC Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2017-2022)
Table 47. APAC Tolbutamide (CAS 64-77-7) Sales by Application (2017-2022) & (Kg)
Table 48. APAC Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2017-2022)
Table 49. Europe Tolbutamide (CAS 64-77-7) Sales by Country (2017-2022) & (Kg)
Table 50. Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Country (2017-2022)
Table 51. Europe Tolbutamide (CAS 64-77-7) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Tolbutamide (CAS 64-77-7) Revenue Market Share by Country (2017-2022)
Table 53. Europe Tolbutamide (CAS 64-77-7) Sales by Type (2017-2022) & (Kg)
Table 54. Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2017-2022)
Table 55. Europe Tolbutamide (CAS 64-77-7) Sales by Application (2017-2022) & (Kg)
Table 56. Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Tolbutamide (CAS 64-77-7) Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Tolbutamide (CAS 64-77-7) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Tolbutamide (CAS 64-77-7) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Tolbutamide (CAS 64-77-7) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Tolbutamide (CAS 64-77-7) Sales by Type (2017-2022) & (Kg)
Table 62. Middle East & Africa Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Tolbutamide (CAS 64-77-7) Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Tolbutamide (CAS 64-77-7)
Table 66. Key Market Challenges & Risks of Tolbutamide (CAS 64-77-7)
Table 67. Key Industry Trends of Tolbutamide (CAS 64-77-7)
Table 68. Tolbutamide (CAS 64-77-7) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Tolbutamide (CAS 64-77-7) Distributors List
Table 71. Tolbutamide (CAS 64-77-7) Customer List
Table 72. Global Tolbutamide (CAS 64-77-7) Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Tolbutamide (CAS 64-77-7) Sales Market Forecast by Region
Table 74. Global Tolbutamide (CAS 64-77-7) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Tolbutamide (CAS 64-77-7) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Tolbutamide (CAS 64-77-7) Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Tolbutamide (CAS 64-77-7) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Tolbutamide (CAS 64-77-7) Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Tolbutamide (CAS 64-77-7) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Tolbutamide (CAS 64-77-7) Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Tolbutamide (CAS 64-77-7) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Tolbutamide (CAS 64-77-7) Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Tolbutamide (CAS 64-77-7) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Tolbutamide (CAS 64-77-7) Sales Forecast by Type (2023-2028) & (Kg)
Table 85. Global Tolbutamide (CAS 64-77-7) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Tolbutamide (CAS 64-77-7) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Tolbutamide (CAS 64-77-7) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Tolbutamide (CAS 64-77-7) Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Tolbutamide (CAS 64-77-7) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Tolbutamide (CAS 64-77-7) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Tolbutamide (CAS 64-77-7) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Pengyao Pharma Basic Information, Tolbutamide (CAS 64-77-7) Manufacturing Base, Sales Area and Its Competitors
Table 93. Pengyao Pharma Tolbutamide (CAS 64-77-7) Product Offered
Table 94. Pengyao Pharma Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 95. Pengyao Pharma Main Business
Table 96. Pengyao Pharma Latest Developments
Table 97. SINE Basic Information, Tolbutamide (CAS 64-77-7) Manufacturing Base, Sales Area and Its Competitors
Table 98. SINE Tolbutamide (CAS 64-77-7) Product Offered
Table 99. SINE Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 100. SINE Main Business
Table 101. SINE Latest Developments
Table 102. Changzhou Pharma Basic Information, Tolbutamide (CAS 64-77-7) Manufacturing Base, Sales Area and Its Competitors
Table 103. Changzhou Pharma Tolbutamide (CAS 64-77-7) Product Offered
Table 104. Changzhou Pharma Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 105. Changzhou Pharma Main Business
Table 106. Changzhou Pharma Latest Developments
Table 107. Changjiang Pharma Basic Information, Tolbutamide (CAS 64-77-7) Manufacturing Base, Sales Area and Its Competitors
Table 108. Changjiang Pharma Tolbutamide (CAS 64-77-7) Product Offered
Table 109. Changjiang Pharma Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 110. Changjiang Pharma Main Business
Table 111. Changjiang Pharma Latest Developments
Table 112. EASHU Pharma Basic Information, Tolbutamide (CAS 64-77-7) Manufacturing Base, Sales Area and Its Competitors
Table 113. EASHU Pharma Tolbutamide (CAS 64-77-7) Product Offered
Table 114. EASHU Pharma Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 115. EASHU Pharma Main Business
Table 116. EASHU Pharma Latest Developments
Table 117. Mylan Basic Information, Tolbutamide (CAS 64-77-7) Manufacturing Base, Sales Area and Its Competitors
Table 118. Mylan Tolbutamide (CAS 64-77-7) Product Offered
Table 119. Mylan Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 120. Mylan Main Business
Table 121. Mylan Latest Developments
Table 122. Sovereign Basic Information, Tolbutamide (CAS 64-77-7) Manufacturing Base, Sales Area and Its Competitors
Table 123. Sovereign Tolbutamide (CAS 64-77-7) Product Offered
Table 124. Sovereign Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 125. Sovereign Main Business
Table 126. Sovereign Latest Developments
Table 127. Vexxa LifeScience Basic Information, Tolbutamide (CAS 64-77-7) Manufacturing Base, Sales Area and Its Competitors
Table 128. Vexxa LifeScience Tolbutamide (CAS 64-77-7) Product Offered
Table 129. Vexxa LifeScience Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 130. Vexxa LifeScience Main Business
Table 131. Vexxa LifeScience Latest Developments
Table 132. Genesis Pharma Basic Information, Tolbutamide (CAS 64-77-7) Manufacturing Base, Sales Area and Its Competitors
Table 133. Genesis Pharma Tolbutamide (CAS 64-77-7) Product Offered
Table 134. Genesis Pharma Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 135. Genesis Pharma Main Business
Table 136. Genesis Pharma Latest Developments
List of Figures
Figure 1. Picture of Tolbutamide (CAS 64-77-7)
Figure 2. Tolbutamide (CAS 64-77-7) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tolbutamide (CAS 64-77-7) Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Tolbutamide (CAS 64-77-7) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Tolbutamide (CAS 64-77-7) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injection
Figure 11. Global Tolbutamide (CAS 64-77-7) Sales Market Share by Type in 2021
Figure 12. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Type (2017-2022)
Figure 13. Tolbutamide (CAS 64-77-7) Consumed in Hospital Pharmacies
Figure 14. Global Tolbutamide (CAS 64-77-7) Market: Hospital Pharmacies (2017-2022) & (Kg)
Figure 15. Tolbutamide (CAS 64-77-7) Consumed in Retail Pharmacies
Figure 16. Global Tolbutamide (CAS 64-77-7) Market: Retail Pharmacies (2017-2022) & (Kg)
Figure 17. Tolbutamide (CAS 64-77-7) Consumed in Online Pharmacies
Figure 18. Global Tolbutamide (CAS 64-77-7) Market: Online Pharmacies (2017-2022) & (Kg)
Figure 19. Global Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2017-2022)
Figure 20. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Application in 2021
Figure 21. Tolbutamide (CAS 64-77-7) Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Company in 2021
Figure 23. Global Tolbutamide (CAS 64-77-7) Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Geographic Region in 2021
Figure 25. Global Tolbutamide (CAS 64-77-7) Sales Market Share by Region (2017-2022)
Figure 26. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Country/Region in 2021
Figure 27. Americas Tolbutamide (CAS 64-77-7) Sales 2017-2022 (Kg)
Figure 28. Americas Tolbutamide (CAS 64-77-7) Revenue 2017-2022 ($ Millions)
Figure 29. APAC Tolbutamide (CAS 64-77-7) Sales 2017-2022 (Kg)
Figure 30. APAC Tolbutamide (CAS 64-77-7) Revenue 2017-2022 ($ Millions)
Figure 31. Europe Tolbutamide (CAS 64-77-7) Sales 2017-2022 (Kg)
Figure 32. Europe Tolbutamide (CAS 64-77-7) Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Tolbutamide (CAS 64-77-7) Sales 2017-2022 (Kg)
Figure 34. Middle East & Africa Tolbutamide (CAS 64-77-7) Revenue 2017-2022 ($ Millions)
Figure 35. Americas Tolbutamide (CAS 64-77-7) Sales Market Share by Country in 2021
Figure 36. Americas Tolbutamide (CAS 64-77-7) Revenue Market Share by Country in 2021
Figure 37. United States Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Tolbutamide (CAS 64-77-7) Sales Market Share by Region in 2021
Figure 42. APAC Tolbutamide (CAS 64-77-7) Revenue Market Share by Regions in 2021
Figure 43. China Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Country in 2021
Figure 50. Europe Tolbutamide (CAS 64-77-7) Revenue Market Share by Country in 2021
Figure 51. Germany Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Tolbutamide (CAS 64-77-7) Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Tolbutamide (CAS 64-77-7) Revenue Market Share by Country in 2021
Figure 58. Egypt Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Tolbutamide (CAS 64-77-7) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Tolbutamide (CAS 64-77-7) in 2021
Figure 64. Manufacturing Process Analysis of Tolbutamide (CAS 64-77-7)
Figure 65. Industry Chain Structure of Tolbutamide (CAS 64-77-7)
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...